The emergence and spread of bacteria carrying the bla NDM-1 gene has become a worldwide concern. Here, we report eight cases of Klebsiella pneumoniae with bla NDM-1 in the neonatal ward of a teaching hospital in mainland China. Multilocus sequence typing showed that seven isolates were clonally related and confirmed them as sequence type 17 (ST17). One isolate belonged to ST433. These findings suggest continuous spread of bla NDM-1 in mainland China and emphasize the need for intensive surveillance and precautions.
T
he emergence of carbapenem-resistant Gram-negative bacteria is a global threat. Antibiotics of the carbapenem family have been a mainstay for the treatment of antibiotic-resistant bacterial infections (1) . Carbapenems can be hydrolyzed by bacterial enzymes, e.g., the New Delhi metallo-beta-lactamase NDM-1. NDM-1 makes bacteria resistant to a broad range of beta-lactam antibiotics, including those of the carbapenem family (2) . NDM-1 was first detected in Escherichia coli and Klebsiella pneumoniae isolated from a Swedish patient of Indian origin in 2008 (3) . Since then, infections associated with NDM-1-positive strains have been reported worldwide, including in India, the United Kingdom, the United States, Canada, Australia, France, Holland, China, Pakistan, Italy, Japan, and Spain (4) . The majority of these reported cases were strains isolated from adult patients (5) . Here, we report an outbreak of NDM-1-producing K. pneumoniae in the neonatal ward of a tertiary teaching hospital in mainland China.
In August 2012, a premature neonate was admitted to our hospital due to poor response after vaginal delivery. The patient developed neonatal sepsis and necrotizing enterocolitis. A carbapenem-resistant K. pneumoniae strain was isolated from the blood culture. There was no documented clinical history of the neonate's parents having a link to an area where NDM-1 is endemic. However, his mother suffered from acute appendicitis in the sixth month of pregnancy and was hospitalized in another hospital in Hunan. The neonate received a 5-day course of meropenem and a 3-day course of ciprofloxacin; however, no adequate clinical response was noted. His parents requested discharge from the hospital against medical advice, and the neonate subsequently died (case 1). In September 2012, another neonate had recurrent fever with cytomegalovirus infection and was also positive for a carbapenem-resistant K. pneumoniae isolate in blood culture. Ceftazidime was given for 10 days, after which the patient recovered (case 2). Successively, four cases were identified. In February 2013, there was also a preterm neonate who had decreased response after birth and displayed severe dyspnea. The patient was initially treated with mezlocillin-sulbactam. An isolate of K. pneumoniae was detected from the sputum. A combination of meropenem and cefoperazone-sulbactam was given for 10 days, and then the patient recovered and was discharged (case 7). By March 2013, eight cases had occurred in the neonatal ward in total. The carbapenem-resistant K. pneumoniae isolates were detected from blood and sputum samples individually. The clinical profiles of all patients are shown in Table 1 .
All isolates were identified as K. pneumoniae by using the BD Phoenix automated microbiology system. Routine determination of antimicrobial susceptibilities was performed using the disk diffusion agar method according to the CLSI standards (6) . It showed that all the isolates were resistant to beta-lactams, including carbapenems, but were susceptible to quinolones and aminoglycosides ( Table 2 ). Production of carbapenemases was detected by the modified Hodge test (6) , and carbapenemase production by all isolates was confirmed. Detection of bla NDM-1 was performed by PCR with designed primers NDM-1-F (5=-GGAAAACTTGATG GA-3=) and NDM-1-R (5=-TAAAACGCCTCTGTC-3=). The PCR products were sequenced and showed 100% identity with bla NDM-1 of K. pneumoniae that is deposited in GenBank with the accession number FN396876.1 (3). To clarify the mechanisms of carbapenem resistance, PCR screening and sequencing for other beta-lactamase genes (bla SHV , bla IMP , bla VIM , bla KPC-2 , bla TEM-1 , bla CTX-M-14 , bla CTX-M-15 , bla CMY-4 , bla CMY-8 , bla OXA-1 , bla OXA-2 , bla OXA-9 , bla OXA-48 , and bla OXA-181 ), fluoroquinolone resistance genes (qnrA, qnrB1, and qnrS), and aminoglycoside resistance genes [aac(3=), aac(6=), aph(3=), and armA] were performed (7, 8) . The results revealed the presence of bla TEM-1 in addition to bla NDM-1 in all isolates. Seven isolates coharbored bla SHV-1 , bla CMY-4 , bla CTX-M-15 , and qnrS. In isolate 7, only bla OXA-2 was detected in addition to bla NDM-1 .
Random amplified polymorphic DNA (RAPD) analysis (9) showed that seven of the K. pneumoniae strains belonged to the same clone. The clonal relationship was further analyzed using multiple locus sequence typing (MLST) according to protocols provided on the MLST websites (http://bigsdb.web.pasteur.fr /klebsiella/klebsiella.html). Seven of the K. pneumoniae isolates were defined as sequence type 17 (ST17), while one belonged to ST433. Neither ST belonged to the most common K. pneumoniae STs (ST14 and ST11) that are reported to harbor NDM-1 (10).
Only one case of NDM-1-positive ST17 has been confirmed, in Guatemala (11). The transferability of bla NDM-1 associated with plasmids was confirmed by broth mating conjugation assays, using E. coli K12J53 as the recipient strain. Transconjugants were selected on MacConkey agar plates containing sodium azide (100 g/ml) and meropenem (0.25 g/ml). Transconjugants revealed resistance to all beta-lactams and carbapenems. PCR and sequencing for transconjugants further confirmed the successful transfer of bla NDM-1 in all the isolates and cotransfer of bla CTX-M-15 in four isolates. This transmissibility with plasmids implies an alarming potential for rapid spread to diverse bacteria.
This report describes a neonatal outbreak of NDM-1-producing K. pneumoniae in mainland China. Since seven isolates analyzed in this outbreak were of the same clonal type, the first neonate was likely the source of this outbreak. His mother had a history of hospitalization during pregnancy and had high risk factors for fetal intrauterine infection. Although this organism was not detected from the mother, we could assume the NDM-1-producing K. pneumoniae might potentially have been colonized in small numbers in the mother's body and infected the fetus through the placental circulation or through the birth canal. Then, the isolate was transmitted between patients and caused nosocomial infection in the ward. In China, various bla NDM-1 -carrying strains of the Enterobacteriaceae have been sporadically identified. The first bla NDM-1 -positive K. pneumoniae isolate in China was identified in Hunan Province in 2012 (12) . Now, this study reports more isolates in the same area. This indicates that Hunan province may be a reservoir of bla NDM-1 that may be unrelated to other areas of NDM endemicity, e.g., India. Among the cases in this study, six patients responded to treatment with ceftazidime and meropenem, which seems inconsistent with the resistance characteristics of the isolates. We considered that five isolates from sputum might be normal flora colonizing the respiratory tract rather than the real pathogen of infection.
After March 2013, more cases occurred, not only in the neona- tal ward but spreading to other departments, including the intensive care unit, neurology ward, and pediatrics ward. Additionally, the bla NDM-1 gene was identified in Escherichia coli, Enterobacter cloacae, and Citrobacter isolates. It is uncertain whether the latter NDM-1-producing isolates were related to the neonatal ward or were imported from the outside. There were reports on NDMproducing bacteria originating from food animals (13) , which indicated a reservoir in the community and connection to animals in China. The progenitor of the NDM-1 remains undefined. In its worrisome situation, the hospital implemented transmissionbased precautions and enhanced environmental cleaning in order to prevent expanded spread. A new study has found that the human gut microbiota is a reservoir of antibiotic resistance genes, but little is known about their diversity and richness within the gut (14) . Further studies are needed to confirm whether NDM-1 is spread from bacteria in the human gut due to excessive use of antibiotics. These findings highlight that epidemiological surveillance of multidrug-resistant microorganisms is indispensable for implementing appropriate interventions.
